Showing results (511-520 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|October 9, 2004
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infectionRoberto Manfredi, Anna Nanetti, Samanta Morelli, et al.
HIV Clinical Trials|October 9, 2004
An example of nonrandom missing data for hepatitis C virus status in a prognostic study among HIV-infected patientsCharlotte Lewden, Hélène Jacqmin-Gadda, Jean-Louis Vildé, et al.
HIV Clinical Trials|October 9, 2004
New hopes for HIV and HCV coinfection in 2004Marina Núñez, Vincent Soriano
HIV Clinical Trials|October 11, 2005
A randomized controlled trial of the clinical utility of genotypic resistance testing in patients with limited prior exposure to antiretroviral drugs
HIV Clinical Trials|November 29, 2007
The safety and efficacy of switching stavudine to tenofovir df in combination with lamivudine and efavirenz in hiv-1-infected patients: three-year follow-up after switching therapyJosé R Valdez Madruga, Isabel Cassetti, Jamal Muhamad A H Suleiman, et al.
HIV Clinical Trials|November 29, 2007
Effectiveness and tolerability of oral administration of low-dose salmon oil to HIV patients with HAART-associated dyslipidemiaJean-Guy Baril, Colin M Kovacs, Sylvie Trottier, et al.
HIV Clinical Trials|November 29, 2007
Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090Scott R Evans, Tzu-Min Yeh, Ned Sacktor, et al.
HIV Clinical Trials|May 14, 2008
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353Y J Bryson, M Mirochnick, A Stek, et al.
HIV Clinical Trials|July 10, 2013
Pharmacokinetics, safety, and tolerability of maraviroc in HIV-negative subjects with impaired renal functionManoli Vourvahis, Juanzhi Fang, Tina Checchio, et al.
HIV Clinical Trials|February 2, 2013
HIV-1 drug resistance and associated factors among adults failing first-line highly active antiretroviral therapy in Ho Chi Minh City, VietnamQuang Duy Pham, Thu Khanh Hoang Huynh, Tram Thu Luong, et al.
Pageof 68